Ultragenyx Pharmaceutical
RARE
#3655
Rank
$3.52 B
Marketcap
$36.54
Share price
0.25%
Change (1 day)
-22.44%
Change (1 year)

Market capitalization of Ultragenyx Pharmaceutical (RARE)

Market cap: $3.52 Billion USD

As of December 2025 Ultragenyx Pharmaceutical has a market cap of $3.52 Billion USD. This makes Ultragenyx Pharmaceutical the world's 3655th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Ultragenyx Pharmaceutical from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025$3.52 B-12.08%
2024$4.00 B2.11%
2023$3.92 B20.9%
2022$3.24 B-43.33%
2021$5.73 B-37.41%
2020$9.15 B270.73%
2019$2.47 B11.71%
2018$2.21 B11.95%
2017$1.97 B-31.24%
2016$2.87 B-34.14%
2015$4.36 B211.27%
2014$1.40 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Ultragenyx Pharmaceutical was reported to be:

$3.52 Billion USD
by Nasdaq info icon info icon
$3.52 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioMarin Pharmaceutical
BMRN
$10.33 B 193.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
$3.06 B-12.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
$0.89 B-74.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
$0.51 B-85.36%๐Ÿ‡บ๐Ÿ‡ธ USA